BlackRock Fund Advisors - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 195 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$60,932,000
-25.0%
560,812
+13.6%
0.01%
-35.3%
Q3 2016$81,253,000
+19.4%
493,670
+3.5%
0.02%
+13.3%
Q2 2016$68,074,000
+13.4%
477,108
+2.1%
0.02%
+7.1%
Q1 2016$60,030,000
-7.8%
467,272
+7.2%
0.01%
-6.7%
Q4 2015$65,114,000
-19.6%
435,983
-10.7%
0.02%
-28.6%
Q3 2015$80,969,000
-25.5%
488,177
+8.5%
0.02%
-19.2%
Q2 2015$108,625,000
-2.1%
450,015
+14.4%
0.03%
-3.7%
Q1 2015$110,925,000
+106.5%
393,324
+14.2%
0.03%
+107.7%
Q4 2014$53,717,000
+133.2%
344,342
+253.8%
0.01%
+85.7%
Q3 2014$23,034,000
+18.8%
97,316
+18.7%
0.01%
+40.0%
Q2 2014$19,397,000
-70.7%
81,970
-59.1%
0.01%
-75.0%
Q1 2014$66,104,000
+397.5%
200,442
+3.0%
0.02%
+400.0%
Q4 2013$13,286,000
-5.2%
194,582
-4.2%
0.00%
-20.0%
Q3 2013$14,022,000
+99.6%
203,136
+29.6%
0.01%
+66.7%
Q2 2013$7,026,000156,6840.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders